You can purchase shares of Processa Pharmaceuticals (NASDAQ:PCSA) through any online brokerage.

View our list of the best stock brokerages

Other companies in Processa Pharmaceuticals’s space includes: Iterum Therapeutics PLC (NASDAQ:ITRM), Gelteq Ltd (NASDAQ:GELS), 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP), Addex Therapeutics Ltd (NASDAQ:ADXN) and Kiora Pharmaceuticals Inc (NASDAQ:KPRX).

Processa Pharmaceuticals has a consensus price target of $3.00.

The stock price for Processa Pharmaceuticals (NASDAQ: PCSA) is $2.1692 last updated March 24, 2026 at 5:53 PM EDT.

There are no upcoming dividends for Processa Pharmaceuticals.

Processa Pharmaceuticals does not have any upcoming earnings scheduled.

There is no upcoming split for Processa Pharmaceuticals.

Processa Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.